Abstract:Abstract Background Atherosclerosis is a chronic lipid-driven inflammatory disease with infiltration of low-density lipoprotein and is considered as the pivotal step in plaque formation. The aim of the review is to get into the fine details of pathophysiologic mechanisms responsible for atherosclerosis with atherosclerotic lesion classification. It also provides a summary of current biomarkers other than the traditional risk factors so that new treatment modalities can emerge and reduce the morbidity and mortality associated with atherosclerosis. Main body In the classification of atherosclerosis made by American Heart Association (AHA), AHA Type I lesion is the earliest vascular change described microscopically. AHA Type II lesion is primarily composed of abundant macrophages. AHA Type III lesion is the earliest of progressive lesions, while AHA Type IV lesion consists of an acellular necrotic core. Various biomarkers are implicated in different stages of the pathophysiological mechanism of plaque formation and evolution. C Reactive Protein plays a direct role in promoting the inflammatory component of atherosclerosis. Fibrinogen was demonstrated to be elevated among patients with acute thrombosis. Higher leukocyte count is associated with a greater cardiovascular risk. Cytokines have been implicated in atheroma formation and complications. High rates of protease activated receptor expression are also induced by interleukin-6 secretion in atherosclerotic lesions and areas of vascular tissue injury. Cluster of differentiation 40 receptor and its ligand have been also detected in atherosclerotic plaques. Osteopontin, acidic phosphoprotein, and osteoprotegerin have emerged as novel markers of atherosclerotic plaque composition. There are also overproductions of matrix metalloproteinases in the rupture-prone regions and promote lipid-necrotic core formation in the atherosclerotic plaque. Myeloperoxidase has been proposed as a marker of plaque instability. Oxidized low-density lipoprotein receptor 1 provides a route of entry for oxidized low-density lipoprotein into the endothelium. A human atherosclerotic lesion also expresses lipoprotein-associated phospholipase A 2 . Short conclusion Atherosclerotic plaques are the battlefield between an unbalanced immune response and lipid accumulation in the intima of arteries. Most of the biomarkers associated with atherosclerosis are indicators of inflammatory response and will also be used for medical purposes.

Targeting Platelet in Atherosclerosis Plaque Formation: Current Knowledge and Future Perspectives

Thrombosis formation on atherosclerotic lesions and plaque rupture

Platelet Implication in Atherosclerosis Pathogenesis

Role of Platelets in the Development of Atherosclerosis.

Platelet-vessel wall interactions in atherosclerotic disease

The Role of Platelets in Atherosclerosis: A Historical Review

Platelets in Thrombosis and Atherosclerosis: A Double-Edged Sword

Platelets, a Key Cell in Inflammation and Atherosclerosis Progression

Novel Aspects Targeting Platelets in Atherosclerotic Cardiovascular Disease—A Translational Perspective

Platelets in Inflammation and Atherogenesis

Platelets as therapeutic targets to prevent atherosclerosis

Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis

Platelets as an inter‐player between hyperlipidaemia and atherosclerosis

Platelets, inflammation and atherosclerosis

Mechanisms of platelets induced atherosclerosis:research progress

The cellular biology of atherosclerosis with atherosclerotic lesion classification and biomarkers

Inhibition of platelet activation and aggregation

Current concepts and novel targets for antiplatelet therapy

Platelets: key players in vascular inflammation

Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease

Platelets in Vascular Calcification: A Comprehensive Review of Platelet-Derived Extracellular Vesicles, Protein Interactions, Platelet Function Indices, and their Impact on Cellular Crosstalk